InvestorsHub Logo

sumbuysumsell

03/27/24 10:38 PM

#455162 RE: Steady_T #455157

Looks like for PDD it is none at all.


Hey. When you guess like that makes it sound like you are being treated like a mushroom. Prolly the best we can do when the company doesn't tell us much.

crescentmotor

03/27/24 10:47 PM

#455164 RE: Steady_T #455157

Looks like for PDD it is none at all.



After all these years, that has to be a pretty safe bet.

bas2020

03/27/24 11:33 PM

#455166 RE: Steady_T #455157

So, you don't think that the PDD data will be included with the AD data in the peer-reviewed journal? Since the two are closely related, it would seem a good opportunity to provide a comprehensive analysis of blarcamesine's efficacy & safety with the implication that it'll be effective therapy in addressing multiple degenerative CNS indications.

I think there's a distinct possibility.